Argenx
ARGX
#524
Rank
S$58.55 B
Marketcap
S$946.18
Share price
0.32%
Change (1 day)
24.25%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: S$58.55 Billion

As of March 2026 Argenx has a market cap of S$58.55 Billion. This makes Argenx the world's 524th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$58.55 B-13.33%
2025S$67.55 B32.71%
2024S$50.90 B70.8%
2023S$29.80 B6.08%
2022S$28.09 B13.01%
2021S$24.86 B34.03%
2020S$18.55 B100.04%
2019S$9.27 B93.6%
2018S$4.78 B78.62%
2017S$2.68 B
2014S$0.19 B

End of Day market cap according to different sources

On Mar 10th, 2026 the market cap of Argenx was reported to be:

S$57.70 Billion
by Nasdaq info icon info icon
S$58.55 Billion
by CompaniesMarketCap info icon info icon